183 related articles for article (PubMed ID: 11037743)
1. Tolerability and efficacy of naratriptan tablets in the acute treatment of migraine attacks for 1 year. Naratriptan Long-Term Study Group.
Heywood J; Bomhof MA; Pradalier A; Thaventhiran L; Winter P; Hassani H
Cephalalgia; 2000 Jun; 20(5):470-4. PubMed ID: 11037743
[TBL] [Abstract][Full Text] [Related]
2. Tolerability and efficacy of naratriptan tablets with long-term treatment (6 months). Naratriptan Long-term Study Group.
Bomhof MA; Heywood J; Pradalier A; Enahoro H; Winter P; Hassani H
Cephalalgia; 1998 Jan; 18(1):33-7. PubMed ID: 9601622
[TBL] [Abstract][Full Text] [Related]
3. Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Naratriptan International Recurrence Study Group.
Göbel H; Winter P; Boswell D; Crisp A; Becker W; Hauge T; Mihout B; Niewold J; Tørring J
Clin Ther; 2000 Aug; 22(8):981-9. PubMed ID: 10972634
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of naratriptan tablets in the acute treatment of migraine: a dose-ranging study. Naratriptan S2WB2004 Study Group.
Havanka H; Dahlöf C; Pop PH; Diener HC; Winter P; Whitehouse H; Hassani H
Clin Ther; 2000 Aug; 22(8):970-80. PubMed ID: 10972633
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies.
Mannix LK; Savani N; Landy S; Valade D; Shackelford S; Ames MH; Jones MW
Headache; 2007; 47(7):1037-49. PubMed ID: 17635595
[TBL] [Abstract][Full Text] [Related]
6. Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials.
Ashcroft DM; Millson D
Pharmacoepidemiol Drug Saf; 2004 Feb; 13(2):73-82. PubMed ID: 14998068
[TBL] [Abstract][Full Text] [Related]
7. Open-label, long-term tolerability of naratriptan for short-term prevention of menstrually related migraine.
Brandes JL; Smith T; Diamond M; Ames MH
Headache; 2007 Jun; 47(6):886-94. PubMed ID: 17578540
[TBL] [Abstract][Full Text] [Related]
8. Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study. The Naratriptan S2WA3003 Study Group.
Mathew NT; Asgharnejad M; Peykamian M; Laurenza A
Neurology; 1997 Dec; 49(6):1485-90. PubMed ID: 9409334
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine.
Garcia-Ramos G; MacGregor EA; Hilliard B; Bordini CA; Leston J; Hettiarachchi J
Cephalalgia; 2003 Nov; 23(9):869-76. PubMed ID: 14616928
[TBL] [Abstract][Full Text] [Related]
10. Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, parallel-group study. Naratriptan S2WA3001 Study Group.
Klassen A; Elkind A; Asgharnejad M; Webster C; Laurenza A
Headache; 1997; 37(10):640-5. PubMed ID: 9439085
[TBL] [Abstract][Full Text] [Related]
11. Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine.
Bomhof M; Paz J; Legg N; Allen C; Vandormael K; Patel K
Eur Neurol; 1999; 42(3):173-9. PubMed ID: 10529545
[TBL] [Abstract][Full Text] [Related]
12. Low migraine headache recurrence with naratriptan: clinical parameters related to recurrence.
Sheftell F; O'Quinn S; Watson C; Pait D; Winter P
Headache; 2000 Feb; 40(2):103-10. PubMed ID: 10759909
[TBL] [Abstract][Full Text] [Related]
13. Naratriptan: an alternative for migraine.
Dulli DA
Ann Pharmacother; 1999 Jun; 33(6):704-11. PubMed ID: 10410185
[TBL] [Abstract][Full Text] [Related]
14. Naratriptan.
Salonen R
Int J Clin Pract; 1999; 53(7):552-6. PubMed ID: 10692743
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
Tuchman M; Hee A; Emeribe U; Silberstein S
CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
[TBL] [Abstract][Full Text] [Related]
16. Tolerability and efficacy of almotriptan in the long-term treatment of migraine.
Pascual J; Falk R; Docekal R; Prusinski A; Jelencsik J; Cabarrocas X; Segarra X; Luria X; Ferrer P
Eur Neurol; 2001; 45(4):206-13. PubMed ID: 11385257
[TBL] [Abstract][Full Text] [Related]
17. A long-term open-label study of oral almotriptan 12.5 mg for the treatment of acute migraine.
Mathew NT;
Headache; 2002 Jan; 42(1):32-40. PubMed ID: 12005273
[TBL] [Abstract][Full Text] [Related]
18. Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study.
Newman L; Mannix LK; Landy S; Silberstein S; Lipton RB; Putnam DG; Watson C; Jöbsis M; Batenhorst A; O'Quinn S
Headache; 2001 Mar; 41(3):248-56. PubMed ID: 11264684
[TBL] [Abstract][Full Text] [Related]
19. Naratriptan efficacy in migraineurs who respond poorly to oral sumatriptan.
Stark S; Spierings EL; McNeal S; Putnam GP; Bolden-Watson CP; O'Quinn S
Headache; 2000; 40(7):513-20. PubMed ID: 10940089
[TBL] [Abstract][Full Text] [Related]
20. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
Dowson AJ; Charlesworth BR; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
CNS Drugs; 2003; 17(11):839-51. PubMed ID: 12921494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
